Ritalin Shortage: Oryza Pharmaceuticals Estimates Availability in January 2027
As of June 2026, the U.S. Food and Drug Administration (FDA) continues to report significant supply chain disruptions for methylphenidate—the active ingredient in Ritalin—and various amphetamine-based stimulants. With Oryza Pharmaceuticals ... Read More